Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths-Reference-Cited by-同舟云学术

Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths

Published:2019-09 Issue: Volume:42 Page:203-212
ISSN:1872-4973
Container-title:Forensic Science International: Genetics
language:en
Short-container-title:Forensic Science International: Genetics

Author:

Martinez-Matilla M.,Blanco-Verea A.,Santori M.,Ansede-Bermejo J.,Ramos-Luis E.,Gil R.,Bermejo AM.,Lotufo-Neto F.,Hirata MH.,Brisighelli F.,Paramo M.,Carracedo A.,Brion M.

Funder

Instituto de Salud Carlos III

FEDER

CNPq

Publisher

Elsevier BV

Subject

Genetics,Pathology and Forensic Medicine

Reference64 articles.

1. The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance;Darpo;Br. J. Pharmacol.,2010

2. International conference on harmonisation; guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice;H. Food;Fed. Regist.,2005

3. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org);Postema;Heart Rhythm,2009

4. Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest;Sicouri;Arrhythm. Electrophysiol. Rev.,2018

5. Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany;Sarganas;Europace,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study;Pharmacogenomics;2024-02

2. Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future;Frontiers in Cardiovascular Medicine;2022-10-13

3. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants;Pharmacogenomics;2022-06

4. Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data;Science Translational Medicine;2021-07-21

5. Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine;Frontiers in Pharmacology;2021-04-30